Plasma N-terminal pro-B-type natriuretic peptide in the detection of aortic valve stenosis

References

• Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J. 2003;24(13):1231–1243. doi: 10.1016/s0195-668x(03)00201-x.
   PubMed Web of Science ®Google Scholar
• Kraler S, Blaser MC, Aikawa E, et al. Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. Eur Heart J. 2022;43(7):683–697. doi: 10.1093/eurheartj/ehab757.
   PubMed Web of Science ®Google Scholar
• Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111(24):3316–3326. doi: 10.1161/CIRCULATIONAHA.104.486738.
   PubMed Web of Science ®Google Scholar
• Sverdlov AL, Ngo DTM, Chan WPA, et al. Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics. Eur Heart J. 2012;33(19):2419–2425. doi: 10.1093/eurheartj/ehs171.
   PubMed Web of Science ®Google Scholar
• Arora S, Misenheimer JA, Ramaraj R. Transcatheter aortic valve replacement: comprehensive review and present status. Tex Heart Inst J. 2017;44(1):29–38. doi: 10.14503/THIJ-16-5852.
   PubMed Web of Science ®Google Scholar
• Coffey S, Cox B, Williams MJA. The prevalence, incidence, progression, and risks of aortic valve sclerosis. J Am Coll Cardiol. 2014;63(25 Pt A):2852–2861. doi: 10.1016/j.jacc.2014.04.018.
   PubMed Web of Science ®Google Scholar
• Gerber IL, Stewart RAH, Legget ME, et al. White, increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003;107(14):1884–1890. doi: 10.1161/01.CIR.0000060533.79248.0C.
   PubMed Web of Science ®Google Scholar
• Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843–849. doi: 10.1136/hrt.2005.071233.
   PubMed Web of Science ®Google Scholar
• Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro–B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol. 2004;94(6):740–745. doi: 10.1016/j.amjcard.2004.05.055.
   PubMed Web of Science ®Google Scholar
• Elmariah S, McCarthy C, Ibrahim N, et al. Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study. Open Heart. 2018;5(2):e000916. doi: 10.1136/openhrt-2018-000916.
   PubMed Web of Science ®Google Scholar
• Nguyen V, Cimadevilla C, Arangalage D, et al. Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis. Int J Cardiol. 2017;230:371–377. doi: 10.1016/j.ijcard.2016.12.100.
   PubMed Web of Science ®Google Scholar
• Qi W, Mathisen P, Kjekshus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J. 2001;142(4):725–732. doi: 10.1067/mhj.2001.117131.
   PubMed Web of Science ®Google Scholar
• Talwar S, Downie PF, Squire IB, et al. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail. 2001;3(1):15–19. doi: 10.1016/s1388-9842(00)00074-x.
   PubMed Web of Science ®Google Scholar
• Prasad N, Bridges AB, Lang CC, et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J. 1997;133(4):477–479.
   PubMed Web of Science ®Google Scholar
• Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109(19):2302–2308. doi: 10.1161/01.CIR.0000126825.50903.18.
   PubMed Web of Science ®Google Scholar
• Lim P, Monin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J. 2004;25(22):2048–2053. doi: 10.1016/j.ehj.2004.09.033.
   PubMed Web of Science ®Google Scholar
• Parikh V, Kim C, Siegel RJ, et al. Natriuretic peptides for risk stratification of patients with valvular aortic stenosis. Circ Heart Fail. 2015;8(2):373–380. doi: 10.1161/CIRCHEARTFAILURE.114.001649.
   PubMed Web of Science ®Google Scholar
• Gomez Perez M, Ble M, Cladellas M, et al. Combined use of tissue Doppler imaging and natriuretic peptides as prognostic marker in asymptomatic aortic stenosis. Int J Cardiol. 2017;228:890–894. doi: 10.1016/j.ijcard.2016.11.144.
   PubMed Web of Science ®Google Scholar
• Poh KK, Chan MYY, Yang H, et al. Prognostication of valvular aortic stenosis using tissue doppler echocardiography: underappreciated importance of late diastolic mitral annular velocity. J Am Soc Echocardiogr. 2008;21(5):475–481. doi: 10.1016/j.echo.2007.08.031.
   PubMed Web of Science ®Google Scholar
• Dichtl W, Alber HF, Feuchtner GM, et al. Prognosis and risk factors in patients With asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). Am J Cardiol. 2008;102(6):743–748. doi: 10.1016/j.amjcard.2008.04.060.
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Popescu BA, Popescu AC, et al. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. Int J Cardiol. 2008;128(3):406–412. doi: 10.1016/j.ijcard.2007.05.039.
   PubMed Web of Science ®Google Scholar
• Monin JL, Lancellotti P, Monchi M, et al. Risk score for predicting outcome in patients With asymptomatic aortic stenosis. Circulation. 2009;120(1):69–75. doi: 10.1161/CIRCULATIONAHA.108.808857.
   PubMed Web of Science ®Google Scholar
• Nessmith MG, Fukuta H, Brucks S, et al. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients With aortic stenosis treated Without surgery. Am J Cardiol. 2005;96(10):1445–1448. doi: 10.1016/j.amjcard.2005.06.092.
   PubMed Web of Science ®Google Scholar
• Clavel MA, Malouf J, Michelena HI, et al. B-Type natriuretic peptide clinical activation in aortic stenosis. J Am Coll Cardiol. 2014;63(19):2016–2025. doi: 10.1016/j.jacc.2014.02.581.
   PubMed Web of Science ®Google Scholar
• Maeder MT, Weber L, Ammann P, et al. Relationship between B-type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis. ESC Heart Fail. 2020;7(2):577–587. doi: 10.1002/ehf2.12614.
   PubMed Web of Science ®Google Scholar
• Abramowitz Y, Chakravarty T, Jilaihawi H, et al. Impact of preprocedural B-Type natriuretic peptide levels on the outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;116(12):1904–1909. doi: 10.1016/j.amjcard.2015.09.031.
   PubMed Web of Science ®Google Scholar
• Roberts E, Ludman AJ, Dworzynski K, et al. on behalf of the NICE guideline development group for acute heart failure, The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 2015;350(mar04 22):h910–h910. doi: 10.1136/bmj.h910.
   PubMedGoogle Scholar
• Di Angelantonio E, Chowdhury R, Sarwar N, et al. B-Type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120(22):2177–2187. doi: 10.1161/CIRCULATIONAHA.109.884866.
   PubMed Web of Science ®Google Scholar
• Mueller C, McDonald K, de Boer RA, et al. on behalf of the heart failure association of the European society of cardiology, heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731. doi: 10.1002/ejhf.1494.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American society of echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18(3):254–275. doi: 10.1093/ehjci/jew335.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64. doi: 10.1016/j.echo.2018.06.004.
   PubMed Web of Science ®Google Scholar
• Aronow WS, Schwartz KS, Koenigsberg M. Correlation of aortic cuspal and aortic root disease with aortic systolic ejection murmurs and with mitral anular calcium in persons older than 62 years in a long-term health care facility. Am J Cardiol. 1986;58(7):651–652. doi: 10.1016/0002-9149(86)90295-x.
   PubMed Web of Science ®Google Scholar
• Iivanainen AM, Lindroos M, Tilvis R, et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol. 1996;78(1):97–101. doi: 10.1016/s0002-9149(96)00235-4.
   PubMed Web of Science ®Google Scholar
• Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8(5):471–483. doi: 10.1093/oxfordjournals.eurheartj.a062307.
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Adams K, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824–839. doi: 10.1016/j.ejheart.2008.07.014.
   PubMed Web of Science ®Google Scholar
• Tzikas S, Keller T, Wild PS, et al. Midregional pro-atrial natriuretic peptide in the general population/insights from the Gutenberg health study. Clin Chem Lab Med. 2013;51(5):1125–1133.
   PubMed Web of Science ®Google Scholar
• Welsh P, Campbell RT, Mooney L, et al. Reference ranges for NT-proBNP (N-Terminal Pro-B-Type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circ Heart Fail. 2022;15(10):e009427.
   PubMed Web of Science ®Google Scholar
• Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135(5 Pt 1):825–832. doi: 10.1016/s0002-8703(98)70041-9.
   PubMed Web of Science ®Google Scholar